Partial lipodystrophy

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
A Gastroenterology (ATC A) 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 1 Phase IV: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Chiesi Farmaceutici S.p.A. Commercial
    METRELEPTIN
    2022-501799-24-00 4 countries 2024 n=16 Orphan
    Ended

Phase IV

1 trial
  • Chiesi Farmaceutici S.p.A. Commercial
    METRELEPTIN
    2022-502950-14-00 3 countries 2023 n=9 Orphan
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Chiesi Farmaceutici S.p.A. Commercial 2 Phase III, Phase IV 1
New trials by year
2023
1
2024
1
← All indication landscapes